The impact of granulocyte-macrophage colony stimulating factor (GM-CSF) on hematologic indexes and complications remains existing contradictory evidence in cancer patients after treatment of chemotherapy. improve bloodstream platelet (SMD = 0.46, 95% CI: -0.37 C -1.29, Z = 1.10, = 0.27). And GM-CSF got significant reference to fever (RR = 3.44, 95% CI: 1.43 C 8.28, Z = 2.76, = 0.006). The publication bias existed in the info from the impact of GM-CSF on blood vessels complication and platelet. In conclusions, GM-CSF had a romantic association with some hematologic problems and indexes. Our research suggested that more hematological indexes and more additional indexes have to be seen in long term research even. of GM-CSF2006Italy/Europeclinical trialCT294821-561 period per 1d (5 mg/kg)87.5%YNathan L 2005America/North Americaclinical trialCT2331-6970-90America1 time per 1d (250g/m2)96%YStephen E 1996America/North Americaclinical trialCT142025-6946-13380America1 time per 1d (250g/m2)97%YA. Le Cesne 2000France/ Europeclinical trialCT2944219-7670Germany1 period per 1d (250g/m2)21.3%YHe 2001China/Asiaclinical trialCT50648-77China1 period per Nelarabine cost 1d (75g/d)92%YZhou 1999China/Asiaclinical trialCT606316-6840-80China1 period per 1d (5g/kg)86.7%YSunlight 2005China/Asiaclinical trialCT287124-7160China1 period per 1d (150g/d)92.9%YLiu 2000China/Asiaclinical trialCT556014-7060China1 time per 1d (5g/kg)73.7%NChen 2003China/Asiaclinical trialCT505823-71 60China1 period Nelarabine cost per 1d (150g/d)YLiu 2000China/Asiaclinical trialCT785423-78 60China1 period per 1d (75g/d)YZhou 1999China/Asiaclinical trialCT606016-7040-9570-100China1 period per 1d (5g/kg)YJi 2015China/Asiaclinical trialCT605025-68China1 period per 1d (100g/d)NYuan 2002China/Asiaclinical trialCT306710-69China1 period per 1d (3-5g/kg)93.33%YZhou 1999China/Asiaclinical trialCT566017-6745-84China1 period per 1d (5g/kg)Y Open up in another window Records: CT: chemotherapy. KPS: Karnofsky Efficiency Status. Y: this article mentions poisonous and unwanted effects. N: this article don’t have or usually do not point out poisonous and unwanted effects. Desk 2 Reporting quality of 15 randomized control tests predicated on the CONSORT 2010 Checklist [n (%)] 0.00001, We2 = 89%, Figure ?Shape2A).2A). We used the random-effect magic size to create figures Therefore. And the effect proven that GM-CSF was connected with improved WBC count number (SMD = 1.16, 95% CI: 0.71 C 1.61, Z = 5.03, 0.00001, Figure ?Shape2A).2A). Furthermore, we analyzed the connections between GM-CSF and the proper period of leukopenia. Five research [18, 20, 21, 23, 26], included 281 individuals, demonstrated the info concerning the result of GM-CSF on the proper time for you to neutropenia. And these research hadn’t homogeneity aswell (2 = 12.76, = 0.01, We2 = 69%, Shape ?Shape2B).2B). Therefore, the data had been calculated from the random-effect model. The effect proven that GM-CSF shortened enough time to WBC count number recovery (SMD = -0.85, 95% CI: -1.16 C -0.54, Z = 5.38, 0.00001, Figure ?Shape2B),2B), gM-CSF could made the WBC count number recovery quicker as a result. Open in another window Shape 2 Forest storyline Rabbit polyclonal to DDX5 showing the bond between GM-CSF and WBC count number(A) Effect of GM-CSF on WBC count number. (B) Effect of GM-CSF for the recovery period of leukopenia. Effect of GM-CSF Nelarabine cost on ANC in tumor patients Eight research [13, 16, 18, 21C24, 26] offered the data concerning ANC, including 533 cancer individuals after chemotherapy. All research got significant heterogeneity (2 = 176.48, 0.00001, We2 = 96%, Figure ?Shape3A).3A). Therefore, Nelarabine cost random-effect model was utilized to calculate them, and the effect recommended that GM-CSF was linked to improved ANC (SMD = 1.11, 95% CI: 0.39 C 1.82, Z = 3.04, = 0.002, Figure ?Shape3A).3A). And, five research [13, 18, 21, 23, 26] reported the info concerning the time for you to neutropenia recovery, including 246 individuals. Homogeneity test exposed not really homogeneity (2= 49.52, 0.00001, We2 = 92%, Figure ?Shape3B),3B), these data had been calculated Nelarabine cost through the use of random-effect model. The effect verified that GM-CSF could shorten enough time to ANC recovery (SMD = -1.47, 95% CI: -2.20 C -1.75, Z = 3.99, 0.0001, Figure ?Shape3B3B). Open up in another window Shape 3 Forest storyline showing the bond between GM-CSF and ANC(A) Effect of GM-CSF on ANC count number. (B) Effect of GM-CSF for the recovery period of neutropenia. Effect of GM-CSF on PLT count number in cancer individuals Six research [13, 16, 18, 24C26] including 375 tumor individuals after chemotherapy, provided the data regarding PLT count number. Homogeneity test demonstrated all studies had been heterogeneous (2.